Skip to main content

SARTORIUS STEDIM BIOTECH Value Stock - Dividend - Research Selection

Sartorius Stedim Biotech S.A

ISIN: FR0013154002, WKN: A2AJKS

Market price date: 21.01.2022
Market price: 377,00 EUR

Sartorius Stedim Biotech S.A Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 26-09-2021
Cash flow
Net operating cash flow 416.879.000
Capital Expenditures -159.192.000
Free cash flow 257.687.008
Balance sheet
Total Equity 1.482.920.000
Liabilities & Shareholders equity 3.069.340.000
Income statement
Net income 357.849.000
Eps (diluted) 3,882
Diluted shares outstanding 92.177.000
Net sales/revenue 1.910.080.000

Fundamental ratios calculated on: 21-01-2022

Key figures 21-01-2022
Cash flow
P/C 83,36
P/FC 134,86
Balance sheet
Income statement
Div. Yield0,18%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization42.147.639.296,00 USD
IndicesSTOXX EUROPE 600,MSCI World Index
SectorsLife Sciences Tools & Services
Raw Data SourceIFRS in Millionen EUR
Stock Split2016-05-06,6.000000/1.000000; 2005-06-16,5.000000/1.000000; 2004-07-13,98163.000000/89239.000000; 2003-07-15,98163.000000/89239.000000; 2002-07-12,98163.000000/89239.000000; 2001-07-11,98163.000000/89239.000000; 1997-05-05,11.000000/10.000000; 1996-01-29,301.000000/292.000000

Description of the company

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,